Skip to content
Search AI Powered

Latest Stories

Reuben McDaniel Resigns from New York's Cannabis Control Board Amid Conflict of Interest Controversy

DASNY president Reuben McDaniel resigns from Cannabis Control Board
DASNY president Reuben McDaniel resigns from Cannabis Control Board
Credit: JOHNNY CRAWFORD / JCRAWFORD@AJC.COM

Reuben McDaniel, a member of the New York Cannabis Control Board (CCB), has stepped down from his position following mounting criticism over allegations of a conflict of interest. McDaniel, who also serves as the president of the Dormitory Authority of the State of New York (DASNY), tendered his resignation during Thursday's CCB meeting.

During the meeting, McDaniel expressed his gratitude for the opportunity to serve on the board and commended Governor Kathy Hochul's vision for advancing cannabis social equity in the state. However, he did not disclose the specific reasons for his departure. CCB Chairwoman Tremaine Wright thanked McDaniel for his service and expressed the board's continued collaboration on the social equity fund.


Former Governor Andrew Cuomo had recommended McDaniel for the presidency of DASNY in 2019, and Governor Hochul appointed him to the five-member CCB in September 2021. However, concerns regarding McDaniel's dual roles have been raised by industry stakeholders. DASNY plays a crucial role in the marketplace rollout, while the Office of Cannabis Management (OCM), which McDaniel oversaw as a CCB board member, has a distinct focus on equity.

The OCM, in its early stages, had developed the Conditional Adult-Use Retail Dispensary (CAURD) program from within DASNY's offices, leading to DASNY's significant involvement in launching the program. This involvement included securing real estate for retailers, finding a fund manager to raise $150 million, and identifying a financial institution for banking services. However, as challenges arose within the CAURD program, such as difficulties in securing real estate and insufficient funding, criticism was directed at DASNY and McDaniel.

Industry stakeholders, including the Cannabis Association of New York, have questioned the potential conflict of interest arising from McDaniel's simultaneous positions. Licensed retailers, in particular, have called for transparency and accountability from DASNY. Some CAURD applicants have accused DASNY of pressuring them into overpriced dispensary locations and providing inflated contractor bids without disclosing loan terms.

Despite his resignation from the CCB, McDaniel will continue to serve as DASNY's president, and the organization will maintain its role in developing New York's cannabis marketplace.

More For You

Comprehensive Glossary of Cannabis Terminology - The Bluntness
Cannabis Terminology - The Bluntness
Photo by Margo Amala on Unsplash

Are You Ready to Master Cannabis Lingo? Explore Essential Terms Now

This glossary covers key cannabis-related terms that can help consumers better understand the cannabis industry, products, and their effects. Whether you're new to cannabis or looking to deepen your knowledge, these definitions offer clarity on common terms you might encounter.

Cannabis Basics: What is Cannabis?

Cannabis is a fascinating plant species that includes three main types: Cannabis sativa, Cannabis indica, and Cannabis ruderalis. Each of these species has unique characteristics and effects. The cannabis plant is a complex organism, rich in various compounds such as cannabinoids, terpenes, and flavonoids. These compounds contribute to the plant’s diverse range of effects and therapeutic benefits. Cannabis plants are cultivated for both medicinal and recreational purposes, and they can be consumed in multiple forms, including dried flower, extracts, and edibles. Whether you’re interested in the energizing effects of Cannabis sativa, the relaxing properties of Cannabis indica, or the unique traits of Cannabis ruderalis, there’s a cannabis plant to suit every need.

Cannabis Products: Cannabis Extracts

Cannabis extracts are highly potent products derived from the cannabis plant using various extraction methods, such as solvents or CO2. These extracts are concentrated forms of cannabis that can be used in several ways, including dabbing, vaporizing, or as ingredients in edibles and topicals. There are several types of cannabis extracts, each with its own texture and potency, including wax, shatter, oil, and crumble. These products are often favored for their high cannabinoid content and are commonly used for medicinal purposes, such as pain relief and anxiety management. Whether you’re looking for a powerful dabbing experience or a potent ingredient for your homemade edibles, cannabis extracts offer a versatile and effective option.

Keep ReadingShow less
a crudely rolled lit joint being passed to camera
Photo by Chase Fade on Unsplash

Alcohol vs Marijuana: Alcohol Worse?

Turns out, your friend who swapped tequila shots for THC gummies might be on to something. A new poll has found that a majority of Americans now believe alcohol is more harmful to a person’s health than marijuana—and frankly, it’s about time. The severe health risks associated with alcohol use, including addiction, various diseases, and a high incidence of mortality, are becoming more widely recognized.

The survey, conducted by YouGov, asked over 1,000 U.S. adults to weigh in on which substance does more damage: good ol’ booze or that plant that’s still somehow federally illegal. The verdict? 64% of respondents said alcohol is more dangerous, compared to just 27% who pointed the finger at weed. The rest? They couldn’t decide or didn’t care enough to pick.

Keep ReadingShow less
image of a circle of doctors and surgeons standing over and looking at a patient on operating room table
New Study Confirms Medical Cannabis Benefits in Cancer Care—Time for Policy to Catch Up
Photo by National Cancer Institute on Unsplash

Cannabis & Cancer: The Evidence Is In—So Why Is the Medical Establishment Still Dragging Its Feet?

If you've ever watched a loved one battle cancer—or been on that journey yourself—you already know the harsh truth: the pain is real, the nausea is relentless, the appetite is gone, and the side effects of treatment often feel worse than the disease. So when patients say cannabis helps, it shouldn’t take 10,000 studies for the medical community to take them seriously.

And yet, here we are.

Keep ReadingShow less
Diverse mix of people sitting outdoors, around a table smiling at camera
Hall of Flowers 2025: Why This Santa Rosa Showcase Remains a Standard Bearer for Cannabis Trade Shows
Press photo provided by Hall of Flowers

Hall of Flowers 2025: Cannabis Trade Show Leader

The cannabis industry has no shortage of events, but very few manage to balance business, culture, and community the way Hall of Flowers does. Since its launch in 2018, the Santa Rosa-based show has become a must-attend gathering for licensed brands, retailers, investors, and innovators.

This year’s edition takes place September 10–11, 2025, at the Sonoma County Fairgrounds, continuing a legacy that goes far beyond trade show floor traffic. Hall of Flowers has become a barometer for where cannabis is now and where it's heading—and how brands and buyers can stay ahead of the curve.

Keep ReadingShow less
image of California coast, pacific coast highway at sunset
How Overregulation Crushed California’s Gold Flora—And Why Other States Should Be Worried
Photo by Matthew Hamilton on Unsplash

Overregulation Kills Gold Flora

When California-based Gold Flora entered the legal cannabis scene, the company was poised to dominate. Backed by serious money and a sprawling, vertically integrated operation—from a 100,000-square-foot cultivation campus in the desert to marquee dispensaries in West Hollywood and San Jose—Gold Flora wasn't just riding the green wave. It was supposed to be the wave.

But by the end of March 2025, the company had filed for receivership, its assets now headed to auction. And while headlines cite "merger woes" and "market conditions," the real culprit behind Gold Flora’s collapse is far more systemic: a regulatory stranglehold that has quietly choked the life out of California’s once-promising cannabis economy.

Keep ReadingShow less